Vaccine

RSV (Respiratory Syncytial Virus) Vaccine

This study will explore whether giving the study vaccine may help protect against RSV infection in people ages 60 and older.

Ages:

60 +

Reimbursement:

up to $500

Trial Length:

Up to 3 years

Qualifications:

  • Ages 60 and older